Author name: pharmazon.co.uk

Simplifying ADHD Treatment Access: Digital Pharmacy Support for Patients & Clinicians When Focus Feels Just Out of Reach It often starts with a small frustration — missed deadlines, forgotten tasks, conversations that drift away mid-sentence. For parents, it can look like constant reminders and endless energy; for adults, it can feel like trying to live […]

UK’s New Wave of Weight-Loss Medications: What You Need to Know & Where to Safely Access Them Over the last few years, the conversation around obesity and weight management in the UK has shifted dramatically. More than ever before, people are exploring medical treatments—especially the new generation of weight loss medications – to help them

With obesity rates rising globally, medical advancements in weight loss treatments have become a hot topic. One of the latest developments is CagriSema, a combination of Cagrilintide and Semaglutide, designed to aid significant weight loss. But how does it work, and when can patients expect it to hit the market?  What is CagriSema?  CagriSema is

Amfexa Amfexa (Dexamfetamine) for ADHD  Amfexa tablets contain the stimulant dexamfetamine, which is prescribed to treat attention-deficit/hyperactivity disorder (ADHD). It is mostly given when other ADHD drugs are ineffective or inappropriate.  Amfexa is typically administered as a component of an all-encompassing treatment plan that may also involve lifestyle modifications, behavioural therapy, and educational support.  Contact

Ozempic for Weight Management Ozempic (semaglutide) is a once-weekly injection designed to assist in managing blood sugar levels in adults with type 2 diabetes mellitus. It works by mimicking the action of glucagon-like peptide-1 (GLP-1), a hormone that plays a crucial role in glucose metabolism. Beyond its primary indication, Ozempic is also prescribed off-label for

Saxenda for Weight Management Saxenda (liraglutide) is indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. It should be used in conjunction with a reduced-calorie diet and increased physical activity. Saxenda mimics the hormone GLP-1, which helps regulate appetite and caloric intake, promoting